The promise and pitfalls of composite endpoints in sepsis and COVID-19 clinical trials.
Pharm Stat
; 20(2): 413-417, 2021 03.
Article
in En
| MEDLINE
| ID: mdl-32893957
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Randomized Controlled Trials as Topic
/
Endpoint Determination
/
COVID-19
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Pharm Stat
Journal subject:
FARMACOLOGIA
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: